セビメリン塩酸塩水和物による口腔リンス法後の血中濃度の推移

DOI Web Site
  • 松原 誠
    朝日大学歯学部口腔病態医療学講座口腔外科学分野
  • 式守 道夫
    朝日大学歯学部口腔病態医療学講座口腔外科学分野
  • 藤本 雅子
    朝日大学歯学部口腔病態医療学講座口腔外科学分野
  • 太田 貴久
    朝日大学歯学部口腔病態医療学講座口腔外科学分野
  • 田中 四郎
    朝日大学歯学部口腔病態医療学講座口腔外科学分野
  • 住友 伸一郎
    朝日大学歯学部口腔病態医療学講座口腔外科学分野

書誌事項

タイトル別名
  • Blood concentration of cevimeline hydrochloride hydrate after oral rinsing
  • セビメリン エンサンエン スイワブツ ニ ヨル コウコウ リンスホウ ゴ ノ ケッチュウ ノウド ノ スイイ

この論文をさがす

説明

Cevimeline hydrochloride hydrate (cevimeline) is used in the treatment of xerostomia associated with Sjogren's syndrome. However, this medication has muscarinic agonist activity and is associated with several adverse effects, including nausea, vomiting, and diarrhea. Oral rinsing with cevimeline is recommended to avoid these adverse effects, but cevimeline blood concentration after rinsing has not been thoroughly investigated. This study measured blood cevimeline concentration after oral rinsing at a concentration of 30 mg in 50 ml of water and determined that the maximum plasma concentration of 4.04 ± 1.10 ng/ml occurred two hours later, which is longer than the time to maximum concentration after an oral administration of 30 mg. Furthermore, the maximum concentration after rinsing was 5.5% of the maximum concentration after oral administration, and the half-life after rinsing was 6 hours, which is longer than the half-life after oral administration.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ